- Home
- XAIR vs AIFF Comparison
XAIR vs AIFF Comparison
Compare XAIR & AIFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XAIR
- AIFF
- Stock Information
- Founded
- XAIR 2011
- AIFF 2006
- Country
- XAIR United States
- AIFF United States
- Employees
- XAIR N/A
- AIFF N/A
- Industry
- XAIR Medical/Dental Instruments
- AIFF
- Sector
- XAIR Health Care
- AIFF
- Exchange
- XAIR Nasdaq
- AIFF NYSE
- Market Cap
- XAIR 17.0M
- AIFF 37.9M
- IPO Year
- XAIR N/A
- AIFF N/A
- Fundamental
- Price
- XAIR $0.18
- AIFF $3.08
- Analyst Decision
- XAIR Strong Buy
- AIFF
- Analyst Count
- XAIR 2
- AIFF 0
- Target Price
- XAIR $1.50
- AIFF N/A
- AVG Volume (30 Days)
- XAIR 5.4M
- AIFF 1.6M
- Earning Date
- XAIR 08-05-2025
- AIFF 08-18-2025
- Dividend Yield
- XAIR N/A
- AIFF N/A
- EPS Growth
- XAIR N/A
- AIFF N/A
- EPS
- XAIR N/A
- AIFF N/A
- Revenue
- XAIR $3,705,000.00
- AIFF $139,000.00
- Revenue This Year
- XAIR $286.75
- AIFF N/A
- Revenue Next Year
- XAIR $144.39
- AIFF N/A
- P/E Ratio
- XAIR N/A
- AIFF N/A
- Revenue Growth
- XAIR 219.67
- AIFF N/A
- 52 Week Low
- XAIR $0.15
- AIFF $1.86
- 52 Week High
- XAIR $0.68
- AIFF $17.20
- Technical
- Relative Strength Index (RSI)
- XAIR 47.34
- AIFF 48.99
- Support Level
- XAIR $0.15
- AIFF $2.70
- Resistance Level
- XAIR $0.29
- AIFF $3.09
- Average True Range (ATR)
- XAIR 0.03
- AIFF 0.26
- MACD
- XAIR -0.00
- AIFF 0.02
- Stochastic Oscillator
- XAIR 19.29
- AIFF 30.84
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.